Patents by Inventor Serguei Nabirotchkin

Serguei Nabirotchkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinatorial therapies of neurological disorders
    Patent number: 10799499
    Abstract: The present invention relates to combinations and methods for the treatment of neurological disorders related Amyloid beta toxicity and/or neuronal death. More specifically, the present invention relates to novel combinatorial therapies of Alzheimer's disease, Alzheimer's disease related disorders, Parkinson's disease, Lewy body dementia, multiple system atrophy and other related synucleinopathies, Huntington's disease, peripheral neuropathies, alcoholism or alcohol withdrawal, neurological manifestations of drug abuse or drug abuse withdrawal, amyotrophic lateral sclerosis, multiple sclerosis, spinal cord injury, epilepsy, traumatic brain injury or brain ischemic events based on 3-phenylsulfonyl-8-(piperazin-1-yl) quinoline and baclofen and/or acamprosate.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: October 13, 2020
    Assignee: PHARNEXT
    Inventors: Daniel Cohen, Serguei Nabirotchkin, Rodolphe Hajj
  • NOVEL COMBINATORIAL THERAPIES OF NEUROLOGICAL DISORDERS
    Publication number: 20190111054
    Abstract: The present invention relates to combinations and methods for the treatment of neurological disorders related Amyloid beta toxicity and/or neuronal death. More specifically, the present invention relates to novel combinatorial therapies of Alzheimer's disease, Alzheimer's disease related disorders, Parkinson's disease, Lewy body dementia, multiple system atrophy and other related synucleinopathies, Huntington's disease, peripheral neuropathies, alcoholism or alcohol withdrawal, neurological manifestations of drug abuse or drug abuse withdrawal, amyotrophic lateral sclerosis, multiple sclerosis, spinal cord injury, epilepsy, traumatic brain injury or brain ischemic events based on 3-phenylsulfonyl-8-(piperazin-1-yl) quinolone and baclofen and/or acamprosate.
    Type: Application
    Filed: February 3, 2017
    Publication date: April 18, 2019
    Inventors: DANIEL COHEN, SERGUEI NABIROTCHKIN, RODOLPHE HAJJ
  • COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES
    Publication number: 20170049777
    Abstract: The present invention relates to compositions and methods for the treatment of diabetic neuropathies. More particularly, this invention relates to compositions and methods for promoting nerve regeneration in a subject suffering from, or at risk of suffering from a diabetic neuropathy, and for protecting nervous system cells against the stresses resulting from the perturbation of glucose homeostasis. More specifically, the present invention relates to novel single or combination therapies for diabetic neuropathies, comprising diabetic peripheral neuropathy, diabetic proximal neuropathy, diabetic autonomic neuropathy and diabetic focal neuropathy, based on restoring dorsal root ganglion neurons and other nerves integrity.
    Type: Application
    Filed: April 29, 2015
    Publication date: February 23, 2017
    Applicant: Pharnext
    Inventors: Daniel Cohen, Ilya Chumakov, Serguei Nabirotchkin, Rodolphe Hajj